Please login to the form below

Not currently logged in
Email:
Password:

Foundry3 set sights on tailored patient support programmes

Agency partners with ERT to improve health outcomes

Matt Baker and Alex Butler

Hoping to bolster its patient support offering through the use of adaptive digital initiatives, Foundry3, a creative, science and innovation agency has teamed up with data and tech group ERT.

The new partnership involves the creation of “tailored” digital health programmes that - the companies say - will improve the clinical outcomes by “providing support to patients throughout their healthcare journeys”.

Alex Butler, co-founder of Foundry3, said: “By partnering with ERT, we leverage their 50 years of scientific, clinical and technology expertise to provide the global scale, structure and governance needed to meet the pharmaceutical industry’s growing demand for more effective global patient support programmes.”

Foundry3 will bring its patient behaviours knowledge to ERT’s expertise in delivering regulatory-compliant drug development and patient support solutions for the pharmaceutical industry.

Tim Davis, vice president, digital patient, ERT, said: “In order to optimise treatment effect and improve quality of life, support programmes must be built around patients’ needs, a critical factor that’s been missing from some of the industry’s digital health initiatives.

“Together with Foundry3, we are able to deliver tailored support programs that patients value because they’re built with patient insight and will truly improve people’s lives.”

Foundry3, which opened its doors earlier this year, has been catapulting out digital initiatives as of late, especially since the launch of Innovation Foundry, which founders Butler and Matt Baker says is the world’s first independent digital health laboratory.

Article by
Gemma Jones

23rd May 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...